These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23683488)

  • 1. Serum prolactin levels in Behçet's disease. Is there a relationship between Behcet's disease and prolactin as in other autoimmune diseases?
    Avci A; Avci D
    Acta Dermatovenerol Croat; 2013; 21(1):52-3. PubMed ID: 23683488
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin levels in Behçet's disease.
    Apaydin KC; Duranoglu Y; Ozgürel Y; Saka O
    Jpn J Ophthalmol; 2000; 44(4):442-5. PubMed ID: 10974304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin levels in Behçet's Syndrome.
    Keser G; Oksel F; Ozgen G; Aksu K; Doganavsargil E
    Clin Rheumatol; 1999; 18(4):351-2. PubMed ID: 10468181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating prolactin levels and Behcet's disease: A meta-analysis.
    Song GG; Lee YH
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):14-18. PubMed ID: 29412808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effects of low (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal cortex functions with Behçet's disease.
    Colak R; Ozkan Y; Cengiz SU; Saral Y; Kandi BC; Halifeoglu I
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):721-5. PubMed ID: 16836503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular involvement in Behçet's disease.
    Takeno M; Sakane T
    Intern Med; 2001 Jan; 40(1):3-4. PubMed ID: 11201366
    [No Abstract]   [Full Text] [Related]  

  • 10. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of vitamins A, C, and E, beta-carotene, selenium, and zinc in patients with Behçet's disease: a controlled study.
    Erel A; Ozsoy E; Biberoğlu G; Bilgihan A; Hasanoğlu A; Yis MO; Atahan C; Oruk S
    Biol Trace Elem Res; 2003 Nov; 95(2):97-106. PubMed ID: 14645991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between serum homocysteine level and eye involvement in Behçet's disease.
    Aflaki E; Mehryar M; Nazarinia MA; Habibagahi Z; Rajaee A; Ranjbar-Omrani G
    Arch Iran Med; 2008 Nov; 11(6):625-8. PubMed ID: 18976033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
    Najim RA; Sharquie KE; Abu-Raghif AR
    J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator receptor levels in Behcet's disease.
    Birengel S; Yalçındağ FN; Yalçındağ A; Sahli E; Batıoğlu F
    Thromb Res; 2011 Sep; 128(3):274-6. PubMed ID: 21470667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.